{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:54:31Z","timestamp":1775580871147,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,27]]},"DOI":"10.7759\/cureus.11208","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T05:02:58Z","timestamp":1603861378000},"source":"Crossref","is-referenced-by-count":4,"title":["Persistent Tenosynovitis, Steroid Dependency and a Hyperpigmented Scaly Macular Rash in a Child With Juvenile Idiopathic Arthritis"],"prefix":"10.7759","author":[{"given":"Eleni Maria","family":"Papatesta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Kossiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Tsolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despoina","family":"Maritsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(85)80394-2","article-title":"Familial granulomatous arthritis, iritis, and rash","volume":"107","author":"Blau EB","year":"1985","unstructured":"Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985, 107:689-693. 10.1016\/s0022-3476(85)80394-2","journal-title":"J Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.07.028","article-title":"Blau syndrome, clinical and genetic aspects","volume":"12","author":"Sfriso P","year":"2012","unstructured":"Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L. Blau syndrome, clinical and genetic aspects. Autoimmun Rev. 2012, 12:44-51. 10.1016\/j.autrev.2012.07.028","journal-title":"Autoimmun Rev"},{"key":"ref3","article-title":"Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16","volume":"59","author":"Tromp G","year":"1996","unstructured":"Tromp G, Kuivaniemi H, Raphael S, et al.. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet. 1996, 59:1097-1107.","journal-title":"Am J Hum Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ng720","article-title":"CARD15 mutations in Blau syndrome","volume":"29","author":"Miceli-Richard C","year":"2001","unstructured":"Miceli-Richard C, Lesage S, Rybojad M, et al.. CARD15 mutations in Blau syndrome. Nat Genet. 2001, 29:19-20. 10.1038\/ng720","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/03009740802464194","article-title":"A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members","volume":"38","author":"Milman N","year":"2009","unstructured":"Milman N, Ursin K, R\u00f8devand E, Nielsen FC, Hansen TV. A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members. Scand J Rheumatol. 2009, 38:190-197. 10.1080\/03009740802464194","journal-title":"Scand J Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.22966","article-title":"NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort","volume":"56","author":"Ar\u00f3stegui JI","year":"2007","unstructured":"Ar\u00f3stegui JI, Arnal C, Merino R, et al.. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum. 2007, 56:3805-3813. 10.1002\/art.22966","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.37776","article-title":"Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis","volume":"65","author":"Simonini G","year":"2013","unstructured":"Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V, Cimaz R. Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum. 2013, 65:513-518. 10.1002\/art.37776","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/463959","article-title":"A new mutation in blau syndrome","volume":"2015","author":"Zeybek C","year":"2015","unstructured":"Zeybek C, Basbozkurt G, Gul D, Demirkaya E, Gok F. A new mutation in blau syndrome. Case Rep Rheumatol. 2015, 2015:463959. 10.1155\/2015\/463959","journal-title":"Case Rep Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5606\/ArchRheumatol.2020.7060","article-title":"Blau syndrome and early-onset sarcoidosis: a six case series and review of the literature","volume":"35","author":"Pa\u00c7 Kisaarslan A","year":"2020","unstructured":"Pa\u00c7 Kisaarslan A, S\u00d6zer\u0130 B, \u015eah\u0130n N, et al.. Blau syndrome and early-onset sarcoidosis: a six case series and review of the literature. Arch Rheumatol. 2020, 35:117-127. 10.5606\/ArchRheumatol.2020.7060","journal-title":"Arch Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu437","article-title":"Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes","volume":"54","author":"Ros\u00e9 CD","year":"2015","unstructured":"Ros\u00e9 CD, Pans S, Casteels I, et al.. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology (Oxford). 2015, 54:1008-1016. 10.1093\/rheumatology\/keu437","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/939847","article-title":"Biological treatments: new weapons in the management of monogenic autoinflammatory disorders","volume":"2013","author":"Vitale A","year":"2013","unstructured":"Vitale A, Rigante D, Lucherini OM, et al.. Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm. 2013, 2013:939847. 10.1155\/2013\/939847","journal-title":"Mediators Inflamm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-2017-5","article-title":"Effective treatment of TNF\u03b1 inhibitors in Chinese patients with Blau syndrome","volume":"21","author":"Chen J","year":"2019","unstructured":"Chen J, Luo Y, Zhao M, Wu D, Yang Y, Zhang W, Shen M. Effective treatment of TNF\u03b1 inhibitors in Chinese patients with Blau syndrome. Arthritis Res Ther. 2019, 21:236. 10.1186\/s13075-019-2017-5","journal-title":"Arthritis Res Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2493-6","article-title":"Early-onset sarcoidosis caused by a rare CARD15\/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature","volume":"34","author":"La Torre F","year":"2015","unstructured":"La Torre F, Lapadula G, Cantarini L, Lucherini OM, Iannone F. Early-onset sarcoidosis caused by a rare CARD15\/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature. Clin Rheumatol. 2015, 34:391-5. 10.1007\/s10067-014-2493-6","journal-title":"Clin Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.24222","article-title":"The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity","volume":"60","author":"Martin TM","year":"2009","unstructured":"Martin TM, Zhang Z, Kurz P, et al.. The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum. 2009, 60:611-618. 10.1002\/art.24222","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00278","article-title":"Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases","volume":"8","author":"Fenini G","year":"2017","unstructured":"Fenini G, Contassot E, French LE. Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases. Front Pharmacol. 2017, 8:278. 10.3389\/fphar.2017.00278","journal-title":"Front Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2014.772","article-title":"Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome","volume":"66","author":"Galozzi P","year":"2015","unstructured":"Galozzi P, Negm O, Greco E, et al.. Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome. Reumatismo. 2015, 66:277-284. 10.4081\/reumatismo.2014.772","journal-title":"Reumatismo"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1006627","article-title":"MDP-induced interleukin-1beta processing requires Nod2 and CIAS1\/NALP3","volume":"82","author":"Pan Q","year":"2007","unstructured":"Pan Q, Mathison J, Fearns C, et al.. MDP-induced interleukin-1beta processing requires Nod2 and CIAS1\/NALP3. J Leukoc Biol. 2007, 82:177-183. 10.1189\/jlb.1006627","journal-title":"J Leukoc Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/41819-persistent-tenosynovitis-steroid-dependency-and-a-hyperpigmented-scaly-macular-rash-in-a-child-with-juvenile-idiopathic-arthritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:18Z","timestamp":1707506358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/41819-persistent-tenosynovitis-steroid-dependency-and-a-hyperpigmented-scaly-macular-rash-in-a-child-with-juvenile-idiopathic-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.11208","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,27]]}}}